The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion.
Annalisa MartinesAngela GrassiAndrea VisentinMonica FaccoSilvia NalioValeria SacchettoElisa PagninAlessandro CelliniRoberta BertorelleFrancesco AngotziLaura BonaldiPublished in: Hematological oncology (2023)